Showing 1 - 20 results of 29 for search 'Umberto Basso', query time: 0.05s
Refine Results
-
1
-
2
-
3
Prognostic Stratification of Metastatic Prostate Cancer Patients Treated With Abiraterone and Enzalutamide Through an Integrated Analysis of Circulating Free microRNAs and Clinical... by Evgeniya Sharova, Marco Maruzzo, Paola Del Bianco, Ilaria Cavallari, Francesco Pierantoni, Umberto Basso, Vincenzo Ciminale, Vincenzo Ciminale, Vittorina Zagonel
Published 2021-03-01
Article -
4
-
5
Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience by Davide Bimbatti, Francesco Pierantoni, Eleonora Lai, Melissa Ballestrin, Nicolò Cavasin, Elisa Erbetta, Chiara De Toni, Umberto Basso, Marco Maruzzo
Published 2023-08-01
Article -
6
Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy by Michele Dionese, Umberto Basso, Francesco Pierantoni, Eleonora Lai, Nicolò Cavasin, Elisa Erbetta, Salim Jubran, Giorgio Bonomi, Davide Bimbatti, Marco Maruzzo
Published 2023-08-01
Article -
7
Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: A case report and review of the literature by Jacopo Lolli, Francesca Tessari, Franco Berti, Marco Fusella, Marco Fusella, Davide Fiorentin, Davide Fiorentin, Davide Bimbatti, Umberto Basso, Fabio Busato, Fabio Busato
Published 2023-03-01
Article -
8
Corrigendum: Impressive reduction of brain metastasis radionecrosis after cabozantinib therapy in metastatic renal carcinoma: a case report and review of the literature by Jacopo Lolli, Francesca Tessari, Franco Berti, Marco Fusella, Marco Fusella, Davide Fiorentin, Davide Fiorentin, Davide Bimbatti, Umberto Basso, Fabio Busato, Fabio Busato
Published 2023-09-01
Article -
9
Glycosaminoglycan Profiling in Patients’ Plasma and Urine Predicts the Occurrence of Metastatic Clear Cell Renal Cell Carcinoma by Francesco Gatto, Nicola Volpi, Helén Nilsson, Intawat Nookaew, Marco Maruzzo, Anna Roma, Martin E. Johansson, Ulrika Stierner, Sven Lundstam, Umberto Basso, Jens Nielsen
Published 2016-05-01
Article -
10
Nivolumab drug holiday in patients treated for metastatic renal cell carcinoma: A real-world, single-centre experience by Davide Bimbatti, Michele Dionese, Michele Dionese, Eleonora Lai, Eleonora Lai, Nicolò Cavasin, Nicolò Cavasin, Umberto Basso, Alvise Mattana, Francesco Pierantoni, Francesco Pierantoni, Vittorina Zagonel, Marco Maruzzo
Published 2022-08-01
Article -
11
Renal cell carcinoma: the population, real world, and cost-of-illness by Alessandra Buja, Giuseppe De Luca, Maura Gatti, Claudia Cozzolino, Massimo Rugge, Manuel Zorzi, Mario Gardi, Matteo Sepulcri, Davide Bimbatti, Vincenzo Baldo, Marco Maruzzo, Umberto Basso, Vittorina Zagonel
Published 2022-12-01
Article -
12
Robotic approach with neoadjuvant chemotherapy in adult Wilms’ tumor: A feasibility study report and a systematic review of the literature by Simone Sforza, Valeria Emma Palmieri, Maria Rosaria Raspollini, Giandomenico Roviello, Alberto Mantovani, Umberto Basso, Maria Carmen Affinita, Alberto D'Angelo, Lorenzo Antonuzzo, Marco Carini, Andrea Minervini, Lorenzo Masieri
Published 2023-04-01
Article -
13
Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14) by Marco Maruzzo, Elena Verzoni, Maria Giuseppa Vitale, Michele Dionese, Michele Dionese, Sebastiano Buti, Luca Galli, Andrea Zivi, Sara Watutantrige-Fernando, Teresa Zielli, Elisa Zanardi, Roberto Sabbatini, Umberto Basso, Vittorina Zagonel, Giuseppe Procopio
Published 2021-11-01
Article -
14
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib by Sara Elena Rebuzzi, Luigi Cerbone, Alessio Signori, Matteo Santoni, Veronica Murianni, Ugo De Giorgi, Giuseppe Procopio, Camillo Porta, Michele Milella, Umberto Basso, Francesco Massari, Marco Maruzzo, Roberto Iacovelli, Nicola Battelli, Luca Carmisciano, Giuseppe Luigi Banna, Sebastiano Buti, Giuseppe Fornarini
Published 2022-02-01
Article -
15
International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26 by Monika Sztankay, Neil K. Aaronson, Juan I. Arraras, Umberto Basso, Uros Bumbasirevic, Fabio Efficace, Johannes M. Giesinger, Colin D. Johnson, Marieke van Leeuwen, Anne S. Oberguggenberger, Roman Sosnowski, Teresa Young, Bernhard Holzner, on behalf of the European Organisation for Research and Treatment of Cancer Quality of Life Group (EORTC QLG)
Published 2018-11-01
Article -
16
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral diseas... by Pierangela Sepe, Giuseppe Procopio, Chiara Carlotta Pircher, Umberto Basso, Orazio Caffo, Vera Cappelletti, Melanie Claps, Ugo De Giorgi, Lucia Fratino, Valentina Guadalupi, Patrizia Miodini, Cinzia De Marco, Bruno Perrucci, Alessia Mennitto, Daniele Santini, Francesco Spina, Marco Stellato, Filippo de Braud, Elena Verzoni
Published 2024-01-01
Article -
17
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study by Lucia Fratino, Jerry Polesel, Emilio Francesco Giunta, Marco Maruzzo, Sebastiano Buti, Mona Ali Hassan, Umberto Basso, Sara Elena Rebuzzi, Ugo De Giorgi, Marika Cinausero, Helga Lipari, Teresa Gamba, Davide Bimbatti, Arianna Dri, Paola Ermacora, Francesca Vignani, Giuseppe Fornarini, Pasquale Rescigno, Giuseppe Luigi Banna
Published 2024-02-01
Article -
18
Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor? by Matteo Santoni, Francesco Massari, Sergio Bracarda, Giuseppe Procopio, Michele Milella, Ugo De Giorgi, Umberto Basso, Gaetano Aurilio, Lorena Incorvaia, Angelo Martignetti, Mimma Rizzo, Giacomo Cartenì, Enrique Grande, Marc R. Matrana, Simon J. Crabb, Nuno Vau, Giulia Sorgentoni, Alessia Cimadamore, Rodolfo Montironi, Nicola Battelli
Published 2021-01-01
Article -
19
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study by Umberto Basso, Federico Paolieri, Mimma Rizzo, Ugo De Giorgi, Sergio Bracarda, Lorenzo Antonuzzo, Francesco Atzori, Giacomo Cartenì, Giuseppe Procopio, Lucia Fratino, Manolo D’Arcangelo, Giuseppe Fornarini, Paolo Zucali, Antonio Cusmai, Matteo Santoni, Stefania Pipitone, Claudia Carella, Stefano Panni, Filippo Maria Deppieri, Vittorina Zagonel, Giampaolo Tortora
Published 2022-05-01
Article -
20
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet‐Uro 19BEYOND study by Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, Daniele Santini, Marco Stellato, Giuseppe Fornarini, Sara Elena Rebuzzi, Umberto Basso, Davide Bimbatti, Laura Doni, Gabriella Nesi, Melissa Bersanelli, Sebastiano Buti, Ugo De Giorgi, Luca Galli, Andrea Sbrana, Raffaele Conca, Claudia Carella, Emanuele Naglieri, Sandro Pignata, Giuseppe Procopio, Lorenzo Antonuzzo
Published 2022-08-01
Article